June 12, 2019
The company is suing the regulatory agency over the approval of Jacobus Pharmaceutical's rival drug Ruzurgi.
May 19, 2019
Last week's top NASDAQ biotech and pharma stocks were Harrow Health, Sesen Bio, Zynerba Pharmaceuticals, Athersys and Catalyst Pharmaceuticals.
March 31, 2019
Aveo Pharmaceuticals, Curis, Phasebio Pharmaceuticals, Arcturus Therapeutics and Krystal Biotech were last week's top gainers.
December 18, 2018
Catalyst Pharmaceuticals (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating, chronic neuromuscular...